简体中文 | 繁體中文 | English

Conference Calls

2020-11-09 14:23 Vifor Pharma and Angion Sign License Agreement for ANG-3777 in Nephrology Indications
2020-11-05 10:06 Zynga Announces Third Quarter 2020 Financial Results
2020-10-28 15:52 IDEMIA Will Present Its Q3 2020 Financial Results to Investors on November 2, 2020
2020-10-26 14:27 Schlumberger Announces Third-Quarter 2020 Results
2020-10-23 13:20 ABB: Q3 2020 Results
2020-10-15 16:04 Bank of America Reports Third-Quarter 2020 Financial Results
2020-10-13 10:30 Dun & Bradstreet Enters Into Agreement to Acquire Bisnode, a Leading European Data & Analytics Business
2020-10-12 16:01 Takeda and Arrowhead Collaborate to Co-Develop and Co-Commercialize ARO-AAT for Alpha-1 Antitrypsin-Associated Liver Disease
2020-09-07 08:43 Schlumberger Announces Third-Quarter 2020 Results Conference Call
2020-08-27 15:13 Phase 2 ELEKTRA Study of Soticlestat (TAK-935/OV935) Meets Primary Endpoint Reducing Seizure Frequency in Children with Dravet Syndrome or Lennox-Gastaut Syndrome
2020-08-07 17:11 Rimini Street Announces Fiscal Second Quarter 2020 Financial Results
2020-08-06 10:00 Zynga Announces Second Quarter 2020 Financial Results
2020-08-05 14:42 Transphorm to Commence Trading on OTC Market Under Symbol “TGAN”
2020-08-03 11:46 Schlumberger Announces Second-Quarter 2020 Results
2020-07-28 12:30 IDEMIA Will Present Its H1 2020 Financial Results to Investors on July 30, 2020
2020-07-22 13:36 ABB: Q2 2020 Results
2020-07-17 14:58 Bank of America Reports Second-Quarter 2020 Financial Results
2020-07-08 13:35 Interactive Brokers Group to Host Second Quarter Earnings Conference Call
2020-07-08 11:24 Lattice Semiconductor Schedules Second Quarter 2020 Results Conference Call
2020-06-18 16:19 Neurocrine Biosciences and Takeda Announce Collaboration to Develop and Commercialize Potential Therapies for Psychiatric Disorders